Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

NeoStem Names Robert Dickey IV As CFO - Quick Facts

RELATED NEWS
Trade NBS now with 

NeoStem Inc. (NBS: Quote) announced that it has appointed Robert Dickey IV as Chief Financial Officer, effective today.

NeoStem stated that Larry May, the company's long-time Chief Financial Officer, is assuming the newly-created position of Vice President, Strategic Initiatives, and will assist Dickey in the transition as well as focus on the company's various strategic activities.

Dickey has over 15 years of management experience at life sciences companies, including positions as a CFO, COO and CEO and board member, following a career as an investment banker.

He has specific expertise in financing, M&A, partnering/licensing transactions and project management, as well as international experience.

Dickey is joining NeoStem from Hemispherx Biopharma, Inc. where he served as Senior Vice President. Prior to Hemispherx , Dickey was Senior Vice President, Chief Financial Officer and Business Unit Manager at StemCyte Inc. Other management experience includes leadership positions at Protarga Inc, and Locus Pharmaceuticals. Previously, he spent 18 years as an investment banker, 14 of those at Lehman Brothers, with a background split between M&A and capital markets transactions across a variety of industries.

Register
To receive FREE breaking news email alerts for Neostem Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter loss widened from last year, hurt mainly by stock-based compensation expense, even as revenue more than doubled thanks to growth in advertising. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. US President Back Obama on Tuesday announced a new round of sanctions against Russia over Moscow's continued involvement in the ongoing conflict in Ukraine, hours after the European Union decided to expand its own sanctions imposed on Russia over the same issue. "Because we are closely coordinating our actions with Europe, the sanctions we are announcing today will have an even bigger bite. After showing a notable move to the upside in early trading on Tuesday, stocks showed a substantial downturn over the course of the session. Concerns about the impact of new sanctions against Russia weighed on the markets.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.